重编程瘤微环境以促进采用T细胞治疗
Maria Fernanda Meza Pacheco1,2, Lee-Hwa Tai1,2
1Departement of Immunology and Cell Biology, Université de Sherbrooke, Sherbrooke, QC, Canada.
Frontiers in immunology
|November 10, 2025
概括
下一代采用性T细胞疗法 (ACT) 需要克服免疫抑制性瘤微环境 (TME). 策略包括重新编程TME并将ACT与传统治疗相结合,以获得更好的固体瘤结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物工程是生物工程.
背景情况:
- 采用T细胞疗法 (ACT) 在血液癌症中表现有前途,但在固体瘤中面临挑战.
- 瘤微环境 (TME) 由于其复杂性和免疫抑制性质,是一个重要的障碍.
研究的目的:
- 审查新兴的增强ACT在固体瘤中的疗效策略.
- 为未来的ACT开发提出一个综合方法,重点关注T细胞-TME相互作用.
主要方法:
- 对TME重编程策略的综合文献综述.
- 分析新兴疗法及其临床转化潜力.
- 探索将传统疗法与ACT整合起来.
主要成果:
- 通过修改TME,几种策略可以提高ACT的疗效,包括血管重编程,髓状细胞再极化,瘤病毒,无菌炎症诱导和向细胞外基质.
- 一些新的方法正在进行临床试验.
- 传统疗法可以战略性地与ACT结合.
结论:
- 未来ACT在固体瘤中的成功取决于重编程TME以支持T细胞功能.
- 结合T细胞工程与TME调制的综合方法至关重要.
- 跨学科的合作对于推动ACT的发展至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


